Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 2/2012

01.04.2012 | Laboratory Investigation

Angiography in the Isolated Perfused Kidney: Radiological Evaluation of Vascular Protection in Tissue Ablation by Nonthermal Irreversible Electroporation

verfasst von: Johann Jakob Wendler, Maciej Pech, Simon Blaschke, Markus Porsch, Andreas Janitzky, Matthias Ulrich, Oliver Dudeck, Jens Ricke, Uwe-Bernd Liehr

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The nonthermal irreversible electroporation (NTIRE) is a novel nonthermal tissue ablation technique by local application of high-voltage current within microseconds leading to a delayed apoptosis. The purpose of this experimental study was the first angiographic evaluation of the acute damage of renal vascular structure in NTIRE.

Methods

Results of conventional dynamic digital substraction angiography (DSA) and visualization of the terminal vascular bed of renal parenchyma by high-resolution X-ray in mammography technique were evaluated before, during, and after NTIRE of three isolated perfused porcine ex vivo kidneys.

Results

In the dedicated investigation, no acute vascular destruction of the renal parenchyma and no dysfunction of the kidney perfusion model were observed during or after NTIRE. Conspicuous were concentric wave-like fluctuations of the DSA contrast agent simultaneous to the NTIRE pulses resulting from NTIRE pulse shock wave.

Conclusion

The NTIRE offers an ablation method with no acute collateral vascular damage in angiographic evaluation.
Literatur
1.
Zurück zum Zitat Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 6(1):37–48PubMed Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 6(1):37–48PubMed
3.
Zurück zum Zitat Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6(4):295–300PubMed Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6(4):295–300PubMed
4.
Zurück zum Zitat Dupuy DE, Aswad B, Ng T (2011) Irreversible electroporation in a swine lung model. Cardiovasc Intervent Radiol 34:391–395PubMedCrossRef Dupuy DE, Aswad B, Ng T (2011) Irreversible electroporation in a swine lung model. Cardiovasc Intervent Radiol 34:391–395PubMedCrossRef
5.
Zurück zum Zitat Sano MB, Neal RE 2nd, Garcia PA, Gerber D, Robertson J, Davalos RV (2010) Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed Eng Online 9(1):83PubMedCrossRef Sano MB, Neal RE 2nd, Garcia PA, Gerber D, Robertson J, Davalos RV (2010) Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed Eng Online 9(1):83PubMedCrossRef
6.
Zurück zum Zitat Deodhar A, Monette S, Single GW Jr, Hamilton WC Jr, Thornton R, Maybody M, Coleman JA, Solomon SB (2011) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77:754–760PubMedCrossRef Deodhar A, Monette S, Single GW Jr, Hamilton WC Jr, Thornton R, Maybody M, Coleman JA, Solomon SB (2011) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77:754–760PubMedCrossRef
7.
Zurück zum Zitat Garcia PA, Neal RE, Rossmeisl JH, Davalos RV (2010) Non-thermal irreversible electroporation for deep intracranial disorders. Conf Proc IEEE Eng Med Biol Soc 1:2743–2746 Garcia PA, Neal RE, Rossmeisl JH, Davalos RV (2010) Non-thermal irreversible electroporation for deep intracranial disorders. Conf Proc IEEE Eng Med Biol Soc 1:2743–2746
8.
Zurück zum Zitat Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford) 12(5):348–351 Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford) 12(5):348–351
9.
Zurück zum Zitat Maor E, Ivorra A, Mitchell JJ, Rubinsky B (2010) Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol 21(11):1708–1715PubMedCrossRef Maor E, Ivorra A, Mitchell JJ, Rubinsky B (2010) Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol 21(11):1708–1715PubMedCrossRef
10.
Zurück zum Zitat Al-Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM (2007) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135PubMedCrossRef Al-Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM (2007) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135PubMedCrossRef
11.
Zurück zum Zitat Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255(2):426–433PubMedCrossRef Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255(2):426–433PubMedCrossRef
12.
Zurück zum Zitat Hong J, Stewart MT, Cheek DS, Francischelli DE, Kirchhof N (2009) Cardiac ablation via electroporation. Conf Proc IEEE Eng Med Biol Soc 2009:3381–3384PubMed Hong J, Stewart MT, Cheek DS, Francischelli DE, Kirchhof N (2009) Cardiac ablation via electroporation. Conf Proc IEEE Eng Med Biol Soc 2009:3381–3384PubMed
13.
Zurück zum Zitat Lee EW, Thai S, Kee ST (2010) Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 4(Suppl 1):S99–S104PubMedCrossRef Lee EW, Thai S, Kee ST (2010) Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 4(Suppl 1):S99–S104PubMedCrossRef
14.
Zurück zum Zitat Goldberg SN, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan JP, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ, International Working Group on Image-Guided Tumor Ablation (2003) Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228(2):335–345PubMedCrossRef Goldberg SN, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan JP, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ, International Working Group on Image-Guided Tumor Ablation (2003) Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228(2):335–345PubMedCrossRef
15.
Zurück zum Zitat Granot Y, Ivorra A, Maor E, Rubinsky B (2009) In vivo imaging of irreversible electroporation by means of electrical impedance tomography. Phys Med Biol 54(16):4927–4943PubMedCrossRef Granot Y, Ivorra A, Maor E, Rubinsky B (2009) In vivo imaging of irreversible electroporation by means of electrical impedance tomography. Phys Med Biol 54(16):4927–4943PubMedCrossRef
16.
Zurück zum Zitat Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6(4):287–294PubMed Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6(4):287–294PubMed
17.
Zurück zum Zitat Thomson KR, Cheung W, Ellis SJ, Park D, Kavnoudias H, Loader-Oliver D, Roberts S, Evans P, Ball C, Haydon A (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22(5):611–621PubMedCrossRef Thomson KR, Cheung W, Ellis SJ, Park D, Kavnoudias H, Loader-Oliver D, Roberts S, Evans P, Ball C, Haydon A (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22(5):611–621PubMedCrossRef
18.
Zurück zum Zitat Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr UB (2011) Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 34:132–138PubMedCrossRef Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr UB (2011) Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 34:132–138PubMedCrossRef
19.
Zurück zum Zitat Ball C, Thomson KR, Kavnoudias H (2010) Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 110(5):1305–1309PubMedCrossRef Ball C, Thomson KR, Kavnoudias H (2010) Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 110(5):1305–1309PubMedCrossRef
20.
Zurück zum Zitat Ljungberg B, Cowan N, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Mulders PFA, Patard JJ, Sinescu IC (2010) Guidelines on Renal Cell Carcinoma. European Association of Urology (EAU). http://www.uroweb.org/. Accessed 25 May 2011 Ljungberg B, Cowan N, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Mulders PFA, Patard JJ, Sinescu IC (2010) Guidelines on Renal Cell Carcinoma. European Association of Urology (EAU). http://​www.​uroweb.​org/​. Accessed 25 May 2011
21.
Zurück zum Zitat Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6(4):307–312PubMed Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6(4):307–312PubMed
22.
Zurück zum Zitat Häcker A, Chauhan S, Peters K, Hildenbrand R, Marlinghaus E, Alken P, Michel MS (2005) Multiple high-intensity focused ultrasound probes for kidney-tissue ablation. J Endourol 19(8):1036–1040PubMedCrossRef Häcker A, Chauhan S, Peters K, Hildenbrand R, Marlinghaus E, Alken P, Michel MS (2005) Multiple high-intensity focused ultrasound probes for kidney-tissue ablation. J Endourol 19(8):1036–1040PubMedCrossRef
23.
Zurück zum Zitat Köhrmann KU, Back W, Bensemann J, Florian J, Weber A, Kahmann F, Rassweiler J, Alken P (1994) The isolated perfused kidney of the pig: new model to evaluate shock wave-induced lesions. J Endourol 8(2):105–110PubMedCrossRef Köhrmann KU, Back W, Bensemann J, Florian J, Weber A, Kahmann F, Rassweiler J, Alken P (1994) The isolated perfused kidney of the pig: new model to evaluate shock wave-induced lesions. J Endourol 8(2):105–110PubMedCrossRef
25.
Zurück zum Zitat Duffey BG, Kyle Anderson J (2010) Current and future technology for minimally invasive ablation of renal cell carcinoma. Indian J Urol 26(3):410–417PubMedCrossRef Duffey BG, Kyle Anderson J (2010) Current and future technology for minimally invasive ablation of renal cell carcinoma. Indian J Urol 26(3):410–417PubMedCrossRef
26.
Zurück zum Zitat Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M (2008) Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 98(2):388–398PubMedCrossRef Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M (2008) Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 98(2):388–398PubMedCrossRef
Metadaten
Titel
Angiography in the Isolated Perfused Kidney: Radiological Evaluation of Vascular Protection in Tissue Ablation by Nonthermal Irreversible Electroporation
verfasst von
Johann Jakob Wendler
Maciej Pech
Simon Blaschke
Markus Porsch
Andreas Janitzky
Matthias Ulrich
Oliver Dudeck
Jens Ricke
Uwe-Bernd Liehr
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 2/2012
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-011-0187-x

Weitere Artikel der Ausgabe 2/2012

CardioVascular and Interventional Radiology 2/2012 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.